Attached files
file | filename |
---|---|
10-K - 10-K - BUNGELTD | bg-12312017x10k.htm |
EX-32.2 - EXHIBIT 32.2 - BUNGELTD | ex-322x123117.htm |
EX-32.1 - EXHIBIT 32.1 - BUNGELTD | ex-321x123117.htm |
EX-31.2 - EXHIBIT 31.2 - BUNGELTD | ex-312x123117.htm |
EX-31.1 - EXHIBIT 31.1 - BUNGELTD | ex-311x123117.htm |
EX-21.1 - EXHIBIT 21.1 - BUNGELTD | listofbungesubsidiaries-ex.htm |
EX-12.1 - EXHIBIT 12.1 - BUNGELTD | ratiosofearningstofixedcha.htm |
EX-10.41 - EXHIBIT 10.41 - BUNGELTD | a2017non-employeedirectors.htm |
EX-10.16 - EXHIBIT 10.16 - BUNGELTD | twelfthamendmenttortaoctob.htm |
EX-10.15 - EXHIBIT 10.15 - BUNGELTD | eleventhamendmenttotherta2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-159918, 333-143529, 333-130651, 333-125426, 333-66594, 333-75762, 333-76938, 333-109446, 333-211908, and 333-218273 on Forms S-8 and Registration Statement Nos. 333-207870, 333-211218, and 333-172608 on Form S-3 of our reports dated February 23, 2018, relating to the consolidated financial statements and financial statement schedule of Bunge Limited and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2017.
/s/ Deloitte & Touche LLP | |
New York, New York | |
February 23, 2018 |